Rising applications of liquid biopsy owing to its advantages over conventional biopsy is
expected to boost growth of the liquid biopsy market:
Liquid biopsy offer efficient disease management as well as non-invasive prenatal testing
(NIPT). NIPT enables diagnosis of potential risks of developing chromosomal
abnormalities such as Edwards’s syndrome, Down syndrome, and X and Y chromosome
abnormalities. Liquid biopsy offers complete genetic profile of the patient by providing
DNA for more than one tumor. The process is non-invasive and provides no biases in
results, owing to heterogeneity of the tumor tissues. The process requires small amount
of sample and is cost and time effectiveness. Furthermore, applications of liquid biopsy
for diagnosis of non-small cell lung cancer (NSCLC), breast cancer, coronary heart
disease, prostate cancer, and others is expected to propel growth of the market. For
instance, according to a new study published in Oncology Journal, in January 2018, the
liquid biopsy combo involving exosomal RNA and cell-free DNA (cfDNA) improved the
sensitivity of epidermal growth factor mutations in NSCLC. Furthermore, OncoCyte
Corporation presented positive data from its breast cancer diagnostic test study, in
December 2017, at San Antonio Breast Cancer Symposium.
Report includes chapters which deeply display the following deliverable about industry :
• Global Liquid Biopsy Market Research Objective and Assumption
• Global Liquid Biopsy Market Purview - Report Description, Executive Summary, and Coherent
Opportunity Map (COM)
• Global Liquid Biopsy Market Dynamics, Regulations, and Trends Analysis - Market Dynamics,
Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals,
Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Global Liquid Biopsy Market, By Regions
• Global Liquid Biopsy Market Competition by Manufacturers including Production, Share,
Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Global Liquid Biopsy Market Manufacturers Profiles/Analysis including Company Basic
Information, Manufacturing Base and Its Competitors.
• Global Liquid Biopsy Market Manufacturing Cost Analysis including Key Raw Materials and
Key Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.